Surgery Partners Stock Math Transform Inverse Tangent Over Price Movement
| SGRY Stock | USD 13.48 0.53 4.09% |
| Symbol |
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Surgery Partners Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Surgery Partners price patterns.
Surgery Partners Technical Analysis Modules
Most technical analysis of Surgery Partners help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Surgery from various momentum indicators to cycle indicators. When you analyze Surgery charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Surgery Partners Inc
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee. Surgery Partners operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 8300 people. As a mid-cap equity, Surgery Partners is reviewed for growth durability, margin stability, and risk discipline. Current metrics include P/E of 61.84, P/B of 0.98, profit margin of -2.35%. Surgery Partners has a market cap of 1.68 B, P/E of 61.84, ROE of 2.76%. 
Gabriel Shpitalnik ยท Member of Macroaxis Editorial Board
Methodology
Unless otherwise specified, financial data for Surgery Partners is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Surgery (USA Stocks:SGRY) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We primarily rely on public filings and market reference sources, including disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR. Data is normalized for analytical consistency across reporting formats. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Surgery Partners may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Surgery Stock is Curated By:
Gabriel Shpitalnik ยท Member of Macroaxis Editorial BoardLearn to be your own money manager
Tracking Surgery Partners inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.
Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Surgery Partners pair trading
Pair trading with Surgery Partners can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
Surgery Partners Pair Trading
Surgery Partners Pair Trading Analysis
Identifying correlated replacements for Surgery Partners is particularly important in concentrated portfolios where Surgery Partners represents a large allocation. A poor substitute could introduce unintended factor or sector risks that persist beyond the required waiting period.
Correlation is not causation, but for Surgery Partners it is a practical tool. High correlations between Surgery Partners and a potential addition to the portfolio flag concentrated exposure, while low correlations signal diversification potential.
Correlation analysis and pair evaluation for Surgery Partners can support hedging context. The method can be applied across sectors and broader equity sets.More Resources for Surgery Stock Analysis
Reviewing Surgery Partners commonly begins with financial statements and performance trends. Financial ratios provide context for profitability, efficiency, and growth trends. Selected reports below provide context for Surgery Stock:Surgery Partners has a market cap of 1.68 B, operating margin of 15.09%, ROE of 2.76%. See World Market Map for portfolio-level analysis. This suggests a position in Surgery Partners within the allocation view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.Our How to Buy Surgery Stock guide explains the steps to invest in Surgery Partners stock.Analysis related to Surgery Partners should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Understanding Surgery Partners includes distinguishing between market value and book value, where book value reflects Surgery accounting equity. Surgery Partners' market capitalization is 1.68 B. A P/B ratio of 0.98 suggests Surgery Partners trades near or below book value. Enterprise value stands at 5.46 B. Intrinsic value is an estimate of underlying worth, separate from trading price and book value. The valuation process compares these measures for perspective.
The concept of value for Surgery Partners differs from its quoted price, since each reflects a different lens. For Surgery Partners, key inputs include a P/E ratio of 61.84, a P/B ratio of 0.98, a profit margin of -2.35%, and ROE of 2.76%. Trading price represents the transaction level agreed by market participants.